Zaki Lababidi, MD
The founder of Gilbert Cardiology, Dr. Zaki Lababidi has over fifteen years of experience in cardiovascular medicine. He is board certified in cardiovascular disease and has specialized in interventional cardiology, a subspecialty of cardiology dedicated to the diagnosis, medical- and catheter-based therapy of patients with acute and chronic forms of cardiovascular disease. Dr. Lababidi also specializes in the treatment of patients with congestive heart failure, coronary artery disease, heart attack, abnormal heart rhythms, peripheral arterial disease (PAD), and varicose veins.
Dr. Lababidi completed his internal medicine residency in 1992 at Mercy Hospital and Medical Center in Chicago, IL. He also served as chief resident from 1991 to 1992. He went on to participate in a cardiology fellowship at Marshall University in Huntington, WV, completing this fellowship in 1995. Dr. Lababidi was in private practice in Chicago, IL for several years prior to returning to fellowship once again in 2004. He completed his interventional cardiology fellowship in 2005 at the Arizona Heart Institute in Phoenix, AZ. Dr. Lababidi founded Gilbert Cardiology in 2007 and has since opened satellite offices in Fountain Hills, AZ and Queen Creek, AZ.
Dr. Lababidi has served in administrative capacities as the Director of the Department of Cardiology at Roseland Community Hospital in Chicago, IL, as well as the Associate Director for the Coronary Care Unit at Mercy Hospital in Chicago, IL. Dr. Lababidi is currently the Director of Echocardiography at Mercy Gilbert Medical Center in Gilbert, AZ. He actively participates in the educational preparation of medical students and serves as Clinical Assistant Professor for Midwestern University.
Over the past few years, Dr. Lababidi has participated in numerous cardiovascular research trials including the MARVEL, CORAL, PROTECT II, and TRACER trials. He has actively participated in a Phase I study of intracardiac injections of autologous myoblasts into transmural scar, as well as the clinical evaluation of drug eluting coronary stent systems. Dr. Lababidi’s research work has been published in the Journal of the American College of Cardiology Intervention, among others.
Dr. Lababidi is currently a member of, and has been appointed, fellow
in the American College of Cardiology and the Society of Cardiovascular
Angiography and Intervention. He is also a member of the Arizona Medical
Association and the American Society of Echocardiography.